Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria ZM Elsayed, WM Eldehna, MM Abdel-Aziz, MA El Hassab, EB Elkaeed, ... Journal of enzyme inhibition and medicinal chemistry 36 (1), 384-392, 2021 | 48 | 2021 |
Synthesis and antitumor activity of certain 2, 3, 6-trisubstituted quinazolin-4 (3H)-one derivatives SE Abbas, FF Barsoum, HH Georgey, ER Mohammed Bulletin of Faculty of Pharmacy, Cairo University 51 (2), 273-282, 2013 | 38 | 2013 |
Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma ER Mohammed, GF Elmasry Journal of enzyme inhibition and medicinal chemistry 37 (1), 686-700, 2022 | 27 | 2022 |
Construction of some cytotoxic agents with aurone and furoaurone scaffolds GS Hassan, HH Georgey, RF George, ER Mohammed Future medicinal chemistry 10 (1), 27-52, 2018 | 20 | 2018 |
Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo [3, 2-a][1, 3, 5] triazine derivatives MH Younis, ER Mohammed, AR Mohamed, MM Abdel-Aziz, HH Georgey, ... Bioorganic Chemistry 124, 105807, 2022 | 19 | 2022 |
Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential MF Said, HH Georgey, ER Mohammed European Journal of Medicinal Chemistry 224, 113682, 2021 | 10 | 2021 |
Discovery of new 2-(3-(naphthalen-2-yl)-4, 5-dihydro-1H-pyrazol-1-yl) thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in … ER Mohammed, AH Abd-El-Fatah, AR Mohamed, MA Mahrouse, ... Bioorganic Chemistry 147, 107372, 2024 | 5 | 2024 |
Exploring new cyclohexane carboxamides based GABA agonist: Design, synthesis, biological evaluation, in silico ADME and docking studies WH Abd-Allah, MAEM Anwar, ER Mohammed, MA Elbaset, ... Bioorganic Chemistry 136, 106561, 2023 | 5 | 2023 |
4-Thiazolidinones: A structural motif of great synthetic and biological activities MH Younis, ER Mohammed, HH Georgey ERU Research Journal 2 (3), 525-540, 2023 | 4 | 2023 |
Anticonvulsant Classes and Possible Mechanism of Actions WH Abd-Allah, MA El-Mohsen Anwar, ER Mohammed, SM El Moghazy ACS Chemical Neuroscience 14 (23), 4076-4092, 2023 | 3 | 2023 |
Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation DEA Rahman, MA Fouad, ER Mohammed, HH El-Zoheiry, HA Allam Bioorganic Chemistry 139, 106678, 2023 | 2 | 2023 |
Exploring new quinazolin‐4(3H)‐one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation BT Ibrahim, HA Allam, NM El‐Dydamony, MA Fouad, ER Mohammed Drug Development Research 85 (2), e22163, 2024 | 1 | 2024 |
Synthesis of S-alkylated oxadiazole bearing imidazo [2, 1-b] thiazole derivatives targeting breast cancer: In vitro cytotoxic evaluation and in vivo radioactive tracing studies ER Mohammed, MAF Ezzat, EM Seif, BM Essa, HA Abdel-Aziz, TM Sakr, ... Bioorganic Chemistry 153, 107935, 2024 | | 2024 |
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors DM Odeh, HA Allam, F Baselious, WR Mahmoud, MM Odeh, HS Ibrahim, ... Drug Development Research 85 (3), e22193, 2024 | | 2024 |